WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...

Credit: Comezora via Getty Images. WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close ...

News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been welcomed by Louth TDs Paula Butterly and Erin McGreehan. Fine Gael TD, Paula ...

What a start to 2025. MSD has agreed to acquire the Wuxi Vaccines manufacturing facility located in Dundalk, Co Louth. Together with the acquisition, the company is looking ahead to significant ...

In a transaction expected to close the first half of the year, Merck, known as MSD outside of the United States and Canada, will be purchasing WuXi Vaccines’ 167,000 square-foot manufacturing plant in ...

In 2017, MSD made the decision to open a ... this year it had decided to build a $360 million manufacturing facility in the Republic of Ireland instead of the UK, blaming the tax burden imposed ...

MSD Ireland, one of Ireland’s leading healthcare companies ... The new expansion is scheduled to commence manufacturing operations in 2022 and will employ an additional 170 staff and 100 contractor ...

GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand ...

GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...

Ireland's manufacturing sector returned to growth in January thanks to fresh impetus in output and new orders, as confidence levels among firms remained close to December's 15-month high, a survey ...